đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The main objective of this study is to compare the immunogenicity of the he...
Status
Completed
Location
Laval University Research Hospital Center
Start Date
2018-06-11
Trial ID
NCT04294433
Treatments Being Tested
This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-23
Trial ID
NCT00753649
Treatments Being Tested
The new formulation administered as a 4th consecutive dose will be compared...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-14
Trial ID
NCT00611559
Treatments Being Tested
The purpose of this study is to assess the immunogenicity, safety and react...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-14
Trial ID
NCT01453998
Treatments Being Tested
The purpose of this trial is to evaluate the immunogenicity and safety of a...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-04-01
Trial ID
NCT00652951
The primary objective of the study was to demonstrate the non-inferiority o...
Status
Completed
Location
Investigational Site Number :8260024
Start Date
2018-10-10
Trial ID
NCT03632720
Treatments Being Tested
The purpose of this trial is to clinically confirm that the manufacturing p...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00404651
This study will evaluate the safety and tolerability and immunogenicity of ...
Status
Completed
Location
Queensland Children s Hospital ( Site 0004)
Start Date
2019-09-04
Trial ID
NCT04031846
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-01-22
Trial ID
NCT02422264
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781